Methods of treating refractory inflammatory disease using transcriptomic and genetic risk signatures
US12264368B2 · kind B2 · utility
0Cited by
16References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2019 |
| Grant date | Apr 1, 2025 |
| Priority date | — |
| Expiry date | May 3, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/065
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Disclosed herein are methods, kits and compositions for treating an inflammatory disease. These methods. kits and compositions may be particularly useful for subjects carrying a risk genotype and/or expressing a transcriptomic risk signature that is indicative of severe inflammatory disease phenotypes for which existing treatment options are limited.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.